Clinical Trial Update: Sitagliptin in Non-Diabetic Patients Undergoing Cardiac Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial update on sitagliptin in non-diabetic patients undergoing cardiac surgery for coronary artery disease; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: Emory University | Conditions: Coronary Artery Disease | Phase 4 | Status: COMPLETED | Results posted: 2018-02-06